Latest oppositions filed by Novo Nordisk A/s

This table presents recent patent oppositions filed by Novo Nordisk A/s against its competitors. It outlines key details of each case, including the patent title, filing date and the applicant. This information provides insights into the competitive landscape and highlights active disputes over patent grant within the industry.

Patent NumberTitleApplicantOpposition Date
EP3056568Methods For Controlling Blood Pharmacokinetics Of AntibodiesCHUGAI SEIYAKU KABUSHIKI KAISHAJun 15, 2022
EP3653223Device For The Oral Delivery Of Therapeutic CompoundsRANI THERAPEUTICS, LLCMay 25, 2022
EP1869065A Method Of Weak Partitioning ChromatographyWYETHFeb 5, 2021
EP3461478Swallowable Drug Delivery DeviceRANI THERAPEUTICS, LLCJan 21, 2021
EP2544668Therapeutic Agent Preparations For Delivery Into A Lumen Of The Intestinal Tract Using A Swallowable Drug Delivery DeviceINCUBE LABS, LLCApr 16, 2020
EP2515992Swallowable Drug Delivery Device And Methods Of Drug DeliveryINCUBE LABS, LLCJul 9, 2019
EP2708559Antigen-Binding Molecule Capable Of Binding To Two Or More Antigen Molecules RepeatedlyCHUGAI SEIYAKU KABUSHIKI KAISHADec 19, 2018
EP2786657A Method Of Producing An Antibody Comprising A Human Variable Region And A Rodent Constant Region.REGENERON PHARMACEUTICALS, INC.Nov 6, 2018

The following table provides an overview of the latest patents of Novo Nordisk A/s that has been opposed by its competitors. It provides an insight into the competitive landscape of the industry and highlights the patents that are subject to oppositions.

Patent NumberGrant DateTitleTotal Oppositions
EP3474820Feb 7, 2024Glp-1 Compositions And Uses Thereof8
EP3250191Jan 17, 2024Tablets Comprising Glp-1 Agonist And Enteric Coating1
EP3488857Oct 4, 2023Compositions Of Glp-1 Peptides And Preparation Thereof5
EP3542790Sep 13, 2023Compositions Comprising A Delivery Agent And Preparation Thereof7
EP3746111Jul 19, 2023Solid Compositions Comprising A Glp-1 Agonist, A Salt Of N-(8-(2-Hydroxybenzoyl)Amino)Caprylic Acid And A Lubricant4
EP3870213Jun 7, 2023Stable Semaglutide Compositions And Uses Thereof1
EP3634468Dec 14, 2022Solid Compositions For Oral Administration1
EP3448416Aug 10, 2022Semaglutide In Cardiovascular Conditions8
EP3423082Aug 4, 2021Liraglutide In Cardiovascular Conditions5
EP2863895Apr 14, 2021Tablet Formulation Comprising A Peptide And A Delivery Agent7